Christopher Gibson (RXRX) logs conversions, sales and RSU vesting in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Recursion Pharmaceuticals director Christopher Gibson reported several stock transactions in early February 2026. On February 4, he converted 40,000 shares of Class B Common Stock into Class A at $0 per share, then sold 40,000 Class A shares at $4.12 under a pre-arranged Rule 10b5-1 trading plan.
On February 6, Gibson received 30,346 Class A shares from restricted stock units that vested immediately at $0, and 10,364 shares were withheld at $3.56 to cover taxes. After these transactions, he directly held 933,821 Class A shares, alongside sizable option and convertible Class B positions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 40,000 shares ($164,800)
Net Sell
14 txns
Insider
Gibson Christopher
Role
Director
Sold
40,000 shs ($165K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 30,346 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 10,364 | $3.56 | $37K |
| Conversion | Class B Common Stock | 40,000 | $0.00 | -- |
| Conversion | Class A Common Stock | 40,000 | $0.00 | -- |
| Sale | Class A Common Stock | 40,000 | $4.12 | $165K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 944,185 shares (Direct);
Class B Common Stock — 4,583,334 shares (Direct);
Class B Common Stock — 0 shares (Indirect, by LAHWRAN-3 LLC);
Stock Option (Right to Buy) — 0 shares (Direct)
Footnotes (1)
- Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. This RSU vested immediately upon the grant date. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
FAQ
What insider transactions did Christopher Gibson report for RXRX in February 2026?
Christopher Gibson reported converting 40,000 Class B shares to Class A, selling 40,000 Class A shares at $4.12, receiving 30,346 Class A shares from vested RSUs, and having 10,364 shares withheld for taxes, all in early February 2026.
Were Christopher Gibson’s February 2026 RXRX stock sales pre-planned?
Yes. The Form 4 states that the February 4, 2026 sale of 40,000 Class A shares at $4.12 occurred under a Rule 10b5-1 trading plan that Gibson adopted on May 12, 2025, indicating the sale followed a pre-established trading program.